REVIEW
|
doi:10.20944/preprints202402.1417.v1
Subject:
Medicine And Pharmacology,
Endocrinology And Metabolism
Keywords:
heart failure; type 1 diabetes; diabetic cardiomyopathy; hospitalization; HFpEF; HFrEF; SGLT2-i; sodium-glucose cotransporter-2 inhibitors; diabetic ketoacidosis; epidemiologic studies; patient education; continuous monitoring of ketone levels; ketonemia
Online: 26 February 2024 (11:54:41 CET)